Myocardial stress perfusion magnetic resonance in children with hypertrophic cardiomyopathy

Cardiology in the Young
Lazaro E Hernandez

Abstract

Microvascular dysfunction in hypertrophic cardiomyopathy has been associated with poor clinical outcome. Several studies have demonstrated a reduced perfusion reserve proportional to the magnitude of the hypertrophy. We investigated the utility of stress perfusion cardiac MRI to detect microvascular dysfunction in children with hypertrophic cardiomyopathy. From January 2016 to January 2017, 13 patients, with a mean age of 15.3 years, with hypertrophic cardiomyopathy underwent regadenoson stress perfusion cardiac MRI (1.5-T Siemens Aera). A single-shot, T1-weighted saturation recovery gradient echo was used for first-pass perfusion in a multiple-slices group, including three short-axis slices and one four-chamber slice. Coronary vasodilatory stress was achieved using bolus injection of regadenoson (lexiscan 0.4 mg/5 ml) and dynamic perfusion during rest and stress performed by administering 0.05 mmol/kg of gadolinium contrast agent (gadoteridol) injected at a rate of 3.5 ml/s, followed by assessment of viability using two-dimensional phase-sensitive inversion recovery of the entire myocardium. All patients completed protocols with no interruptions. In all, seven patients developed perfusion defects after the administration of re...Continue Reading

References

Jun 1, 1995·Histopathology·M J Davies, W J McKenna
Mar 12, 2002·JAMA : the Journal of the American Medical Association·Barry J Maron
Mar 26, 2003·Hypertension·Roberta MaestriPaolo Madeddu
Sep 12, 2003·The New England Journal of Medicine·Franco CecchiPaolo G Camici
Jun 3, 2004·The Annals of Thoracic Surgery·Ingeborg FriehsPedro J del Nido
Jan 9, 2009·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Tomás F CianciulliLuis A Vidal
Sep 19, 2009·Journal of the American College of Cardiology·Wael Al Jaroudi, Ami E Iskandrian
Oct 22, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Barry J Maron
Feb 22, 2012·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Radwa A NoureldinDavid A Bluemke
Jan 1, 2013·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Nicole M BhaveAmit R Patel
Sep 26, 2013·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Sujethra VasuAndrew E Arai
Aug 28, 2014·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Tevfik F IsmailAndrew E Arai
Jun 13, 2015·Pediatric Cardiology·Robert JablonowskiMarcus Carlsson
Jan 16, 2016·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Adriana D M VillaAmedeo Chiribiri

❮ Previous
Next ❯

Citations

Mar 3, 2021·Journal of the American College of Radiology : JACR·UNKNOWN Expert Panel on Cardiac ImagingSuhny Abbara
Jul 11, 2021·Pediatric Cardiology·Jeffrey A HutchensR Mark Payne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.